financetom
Business
financetom
/
Business
/
LandBridge Posts Higher Q1 Profit, Revenue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LandBridge Posts Higher Q1 Profit, Revenue
May 26, 2025 3:38 AM

05:43 PM EDT, 05/07/2025 (MT Newswires) -- LandBridge Company ( LB ) late Wednesday reported Q1 net income of $15.5 million, up from $10.8 million a year ago.

Revenue grew to $44.0 million from $19.0 million a year earlier.

Analysts polled by FactSet expected $43.7 million.

The company kept its quarterly dividend at $0.10 per share, payable June 19 to holders of record June 5.

LandBridge ( LB ) also reaffirmed its full-year 2025 adjusted EBITDA guidance of $170 million to $190 million.

Shares were down about 1.2% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Update: IDEXX Laboratories Shares Climb After Q2 Beat, 2025 Guidance Lifted
Update: IDEXX Laboratories Shares Climb After Q2 Beat, 2025 Guidance Lifted
Aug 4, 2025
10:34 AM EDT, 08/04/2025 (MT Newswires) -- (Updates with recent stock move in headline and first paragraph.) IDEXX Laboratories ( IDXX ) shares were up 24% in recent trading Monday after the company posted stronger-than-expected Q2 earnings and revenue, and boosted its 2025 guidance. The company reported Q2 earnings Monday of $3.63 per diluted share, up from $2.44 a year...
Update: TG Therapeutics Shares Fall After Q2 Earnings Miss Expectations
Update: TG Therapeutics Shares Fall After Q2 Earnings Miss Expectations
Aug 4, 2025
10:34 AM EDT, 08/04/2025 (MT Newswires) -- (Updates with recent share price movement in the headline and first paragraph and analyst expectations for full-year revenue in the final paragraph.) TG Therapeutics ( TGTX ) shares were down over 16% in recent Monday trading after the company reported Q2 earnings that increased year-over-year but fell short of analyst expectations. The company...
--Gyrodyne Share Trading Halted on NASDAQ, Pending Material News Release
--Gyrodyne Share Trading Halted on NASDAQ, Pending Material News Release
Aug 4, 2025
10:41 AM EDT, 08/04/2025 (MT Newswires) -- Price: 10.76, Change: +1.56, Percent Change: +16.96 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved